Hackman Jeffrey S. 4
4 · FENNEC PHARMACEUTICALS INC. · Filed May 19, 2025
Insider Transaction Report
Form 4
Hackman Jeffrey S.
DirectorChief Executive Officer
Transactions
- Purchase
Common Shares
2025-05-16$6.75/sh+1,035$6,986→ 1,035 total - Purchase
Common Shares
2025-05-19$6.99/sh+13,965$97,615→ 15,000 total
Footnotes (1)
- [F1]Transaction Code P - Open market or private purchase of non-derivative or derivative security